JP2000512996A5 - - Google Patents

Download PDF

Info

Publication number
JP2000512996A5
JP2000512996A5 JP1998503010A JP50301098A JP2000512996A5 JP 2000512996 A5 JP2000512996 A5 JP 2000512996A5 JP 1998503010 A JP1998503010 A JP 1998503010A JP 50301098 A JP50301098 A JP 50301098A JP 2000512996 A5 JP2000512996 A5 JP 2000512996A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998503010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000512996A (ja
Filing date
Publication date
Priority claimed from US08/670,201 external-priority patent/US5716987A/en
Application filed filed Critical
Publication of JP2000512996A publication Critical patent/JP2000512996A/ja
Publication of JP2000512996A5 publication Critical patent/JP2000512996A5/ja
Withdrawn legal-status Critical Current

Links

JP10503010A 1996-06-21 1997-06-17 皮膚感作および刺激の予防および治療措置 Withdrawn JP2000512996A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/670,201 US5716987A (en) 1996-06-21 1996-06-21 Prophylactic and therapeutic treatment of skin sensitization and irritation
US08/670,201 1996-06-21
PCT/US1997/009318 WO1997048369A2 (en) 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation

Publications (2)

Publication Number Publication Date
JP2000512996A JP2000512996A (ja) 2000-10-03
JP2000512996A5 true JP2000512996A5 (enExample) 2004-11-25

Family

ID=24689424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10503010A Withdrawn JP2000512996A (ja) 1996-06-21 1997-06-17 皮膚感作および刺激の予防および治療措置

Country Status (7)

Country Link
US (2) US5716987A (enExample)
EP (1) EP0954300A4 (enExample)
JP (1) JP2000512996A (enExample)
AU (1) AU716125B2 (enExample)
CA (1) CA2258736A1 (enExample)
NZ (1) NZ333324A (enExample)
WO (1) WO1997048369A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605642B2 (en) 1999-04-05 2003-08-12 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGES)
US7030133B2 (en) * 1999-04-05 2006-04-18 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6337350B1 (en) 1999-04-05 2002-01-08 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
AU1773601A (en) * 1999-11-18 2001-05-30 John D. Bolla Treatment or prevention of photoaging and skin cancer
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
AU2004287434B2 (en) * 2003-10-27 2011-04-07 City Of Hope Methods of lowering lipid levels in a mammal
CA2567437A1 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
US7399493B2 (en) * 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020102695A1 (en) 2018-11-16 2020-05-22 Cti (Assignment For Benefit Of Creditors) Llc Thermally regulated transdermal drug delivery system
US11865602B2 (en) * 2020-01-16 2024-01-09 Ehc Inc. Paintless dent removal tool, system and method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383662A1 (fr) * 1977-03-15 1978-10-13 Cassenne Lab Sa Nouvelles compositions a usage cosmetique
JPS55133304A (en) * 1979-04-05 1980-10-17 Shiseido Co Ltd Perfume controller
US4524214A (en) * 1983-11-03 1985-06-18 Stauffer Chemical Company Process for forming esters of glyoxylic acids
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
DE4225794C2 (de) * 1992-07-31 1994-12-08 Schuelke & Mayr Gmbh Tb-wirksame Carbonsäuren

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)